| 000 | 01564 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513200919.0 | ||
| 264 | 0 | _c20000405 | |
| 008 | 200004s 0 0 eng d | ||
| 022 | _a0271-3683 | ||
| 024 | 7 |
_a10.1076/0271-3683(200002)20:2;1-d;ft085 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDe Saint Jean, M | |
| 245 | 0 | 0 |
_aToxicity of preserved and unpreserved antiglaucoma topical drugs in an in vitro model of conjunctival cells. _h[electronic resource] |
| 260 |
_bCurrent eye research _cFeb 2000 |
||
| 300 |
_a85-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aBenzalkonium Compounds _xtoxicity |
| 650 | 0 | 4 |
_aCell Count _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 |
_aChromatin _xdrug effects |
| 650 | 0 | 4 |
_aConjunctiva _xcytology |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 |
_aFree Radicals _xmetabolism |
| 650 | 0 | 4 |
_aGlaucoma _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrogen Peroxide _xpharmacology |
| 650 | 0 | 4 |
_aPreservatives, Pharmaceutical _xtoxicity |
| 650 | 0 | 4 |
_aTimolol _xpharmacology |
| 650 | 0 | 4 | _aToxicity Tests |
| 700 | 1 | _aDebbasch, C | |
| 700 | 1 | _aBrignole, F | |
| 700 | 1 | _aRat, P | |
| 700 | 1 | _aWarnet, J M | |
| 700 | 1 | _aBaudouin, C | |
| 773 | 0 |
_tCurrent eye research _gvol. 20 _gno. 2 _gp. 85-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1076/0271-3683(200002)20:2;1-d;ft085 _zAvailable from publisher's website |
| 999 |
_c10573593 _d10573593 |
||